| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |